Inulin (Chicory Root Fibre)

What It Is

Inulin is a soluble fibre: a fructan, a chain built mostly of fructose units, which the small intestine cannot digest or absorb. Extracted from chicory root, it goes by several names on ingredient lists. FDA’s 2018 review lists “inulin, chicory root extract, chicory root, chicory root fiber, inulin from chicory, chicory vegetable fiber, fructooligosaccharide, and oligofructose”. This page covers native chicory inulin and its shorter-chain forms, oligofructose and short-chain fructooligosaccharides (FOS), which FDA treats together as “inulin and inulin-type fructans”.

It is not really a sweetener. Oligofructose and short-chain FOS have “a sweetness value of 30%–35% that of sucrose”, according to a 2023 review, and native inulin is less sweet still; we found no measured figure for it. In “sugar-free” bars and baked goods it is the bulk, paired with another sweetener. It is on this site because of what a label with chicory root fibre does and does not tell you.

Calories, Carbohydrate and Net Carbs

There is no inulin-specific calorie factor. US regulations set “a general factor of 2 calories per gram for soluble non-digestible carbohydrates”, and the EU’s factor for fibre is also 2 kcal per gram. That energy reaches the body only after bacteria in the colon ferment the fibre, not as glucose.

This site subtracts the fibre grams in full from net carbs. Adopting EFSA’s view, the European Commission says non-digestible carbohydrates “do not contribute to postprandial glycaemia”. Two limits apply:

• The ingredient is not pure fibre. The EU’s own definition of native chicory inulin allows less than 10% monosaccharides, plus disaccharides. Those free sugars count, and appear under Total Sugars.
• Acid breaks it down. “at pH <4, ITF are hydrolyzed”, into shorter chains and fructose. In acidic drinks and yogurts, the fibre on the label can overstate what is left by the end of shelf life, and the fructose released is a sugar.

So subtract the label’s Dietary Fiber grams, never the weight of the ingredient. One labelling difference matters here. On a US label, fibre sits inside Total Carbohydrate. On an EU label it does not: carbohydrate there means carbohydrate “which is metabolised by humans”, and fibre is declared separately. An EU carbohydrate figure has already left the inulin out, so subtracting it again would double-count.

Blood Glucose: A Replacement Effect, Not a Treatment

When inulin replaces sugar, the rise in blood glucose after eating is smaller. Two double-blind crossover trials, of 40 to 42 people, found that yogurt with 20% less sugar and fruit jelly with 30% less sugar, made up with oligofructose or inulin, lowered the glucose response, and “The reduction of postprandial glycaemia was positively correlated to the proportion of sugars replaced”. Two of the authors are affiliated with the BENEO-Institute; BENEO makes chicory inulin. This is a replacement effect: less sugar, less glucose. It is also all the EU’s authorised claim says.

The long-term evidence is weaker than it first looks. A 2019 meta-analysis of 33 trials reported that inulin-type fructans lowered fasting glucose by 0.60 mmol/L and HbA1c by 0.58 percentage points in people with prediabetes or type 2 diabetes. Its own subgroup table, across all its trials, shows where that comes from:

• Trials in Iran: HbA1c -0.75 points (95% CI -1.00 to -0.50).
• Trials in all other countries: HbA1c -0.08 points (95% CI -0.27 to 0.11), not significant; fasting glucose -0.10 mmol/L (-0.22 to 0.02), also not significant.

In the same subgroup analysis, the eight industry-sponsored trials showed no effect (-0.01). The review itself declared no competing interests. Its headline result rests on one country’s trials, and we found no published glycaemic index for inulin or oligofructose. We would not count on inulin to lower HbA1c.

Tolerance, and Why IBS Changes Everything

A 2022 review of 17 inulin and 17 FOS trials in adults: “Low doses of 0.75–5 g/d inulin led to only mild flatulence, medium doses of 7.5–20 g/d led to mild and moderate symptoms, and higher doses (≥22 g/d) resulted in study dropouts”. For oligofructose or FOS it suggests staying at or below 7.8 g a day. Its publication fees were paid by an industry-pooled committee, and one author has received grants from food companies and speaking fees from Beneo.

Shorter chains are harder on the gut. In a Cargill-funded trial of 26 young adults, up to 10 g a day of native inulin and up to 5 g of oligofructose were well tolerated, but “The 10-g dose of oligofructose substantially increased GI symptoms”. The EU’s bowel-function claim needs 12 g of native inulin a day, above the review’s comfortable range.

Inulin is a FODMAP, and for people with irritable bowel syndrome that is the main fact on this page. In a double-blind rechallenge of 25 people with IBS who had improved on a low-fructose, low-fructan diet, symptoms were not adequately controlled in 77% of those given fructans, against 14% given glucose. In a 2017 study with no industry funding, 40 g of inulin brought 13 of 29 IBS patients to the symptom threshold, against 6 of 29 after glucose. Inulin raised colonic gas equally in patients and in healthy people, so the symptoms come from a sensitive bowel, not from extra gas. Chicory root fibre in a “sugar-free” bar is a common trigger that people do not recognise.

We found no laxative-label requirement for inulin in US or EU rules. The EU’s statement applies to polyols, and inulin is not one. That is an absence in the texts we opened, not a ruling that none is needed.

Regulatory Status

• US, safety: GRAS by notification. FDA had “no questions” about the first chicory inulin notice in 2003, for use “as a bulking agent”, and later notices for oligofructose, long-chain inulin and short-chain FOS. It is not affirmed in FDA’s regulations.
• US, fibre: inulin is not on the regulation’s list of dietary fibres. FDA’s Q&A, current as of 25 July 2024, still lists it among fibres FDA “intends to propose”, and allows it on the Dietary Fiber line “Until FDA completes rulemaking”. That is enforcement discretion, since 2018. FDA’s 2018 science review accepted inulin on evidence for calcium absorption and bone mineral density, not on gut or blood-glucose effects, and noted that it lacks “some of the typical properties of other soluble dietary fibers, such as viscosity”.
• EU: treated as a food constituent with one authorised claim: “Chicory inulin contributes to normal bowel function by increasing stool frequency”, for foods providing at least 12 g a day of native chicory inulin. That excludes oligofructose and short-chain FOS. The applicant was BENEO-Orafti, and the conditions rest partly on its “unpublished study report”. A generic claim lets foods with non-digestible carbohydrates “instead of sugars” claim a lower blood glucose rise; EFSA found that effect is not specific to inulin. A calcium-absorption claim for children was refused because the fibres named “were not sufficiently characterised”. We found no E number, but did not open the EU additive register to confirm it.

In the Kitchen

Inulin is stable at neutral pH but breaks down below pH 4. Unlike the polyols, it takes part in Maillard browning: “ITF is a mixture of reducing and nonreducing oligosaccharides”, and bread with 5% inulin-type fructans “darkened 3 min quicker” than bread with less. Long-chain inulin “can form fat‐mimicking gels” above about 10 to 20%, so it also turns up as a fat replacer.

Comparison Note

Against the polyols, such as erythritol, sorbitol and maltitol: inulin is a fibre, not a sugar alcohol. Its fibre grams are subtracted in full here because it is not absorbed in the small intestine, while sorbitol and maltitol are partly absorbed and count half. Like them, it sets its own limit through the gut, and like sorbitol it is a FODMAP. Against yacon syrup: yacon’s FOS are the same kind of fibre, but the syrup also carries a quarter to over half free sugar.

What would change this page: an FDA final rule adding inulin to the definition of dietary fibre, or ending the discretion; an independent long-term HbA1c trial in type 2 diabetes outside Iran; or a published glycaemic index for commercial inulin and oligofructose that includes their free sugars.